Pharma & Biotech News #PharmaBuzz

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Weekly News Recap #Phispers

Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

In Phispers this week, Eli Lilly announced its plans to invest US$ 3 billion in China over the next decade in order to build p...

Impressions : 2070

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Over the past week, tensions in the Middle East have escalated sharply after the US and Israel launched military strikes on Ira...

Impressions : 583

Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia

In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...

Impressions : 669

FDA agrees to review Moderna's amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...

Impressions : 1537

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia

FDA agrees to review Moderna's amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

Zydus' Generics Cevimeline HCl Receives Approval in US

Humanwell's Generics Desvenlafaxine Receives Approval in US

Difgen Pharms' Generics Mesalamine Receives Approval in US

Apotex's Generics Sitagliptin Receives Tentative Approval in US

Strides's Generics Milnacipran Receives Tentative Approval in US

Steranco's Generics Oxcarbazepine Receives Approval in US

Contract Pharmacal's Generics Famotidine Receives Approval in US

Knack's Generics Dexmedetomidine HCl Receives Approval in US

Micro's Generics Bisoprolol Fumarate Receives Approval in US

E5 Pharma's Generics Ivermectin Receives Approval in US

Enforcement Report - Week of March 11, 2026

Halewood Lab Fails EDQM Inspection

FDA Issues Form 483 to Novo Nordisk

Novo Nordisk's Receives FDA Warning Letter

Simtra BioPharma Solutions' Receives FDA Warning Letter

NSE Products' Receives FDA Warning Letter

Fareva Morton Grove's Receives FDA Warning Letter

Tentamus' Receives FDA Warning Letter

FDA Issues Form 483 to Maiva Pharma

Enforcement Report - Week of March 4, 2026

Cannabis Not As Effective For Mental Health Disorders

Genentech CEO Says Aiming for Tolerable, Affordable Obesity drugs

Middle East War Forces Pharma To Reroute Drugs To Australia

Bicycle Pumps Brakes on Lead Program, Deflates Headcount by 30%

Indiana Governor Pledges $1B to Life Sciences, Agroscience

Pfizer's Ibrance Heir Reduces Risk of Death in Ph 2 Breast Cancer

FDA Rejects Aldeyra Eye Disease Candidate for 3rd Time

Strides Acquires Sandoz Generic Brands to Boost Africa Business

SC Grills SEBI on Sandesara Probe Despite 5,100 Cr Settlement

Middle East war disrupts pharma air routes, risks cancer drugs

Strides Acquires Sandoz Generic Brands to Boost Africa Business

Glenmark Pharma USA Launches Potassium Phosphates Injection USP

Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement

Ozempic Generics Set To Disrupt India's Weight-Loss Market

Caplin Steriles Secures USFDA Approval For Potassium Phosphates

Zydus Gets USFDA Nod For Cevimeline HCL Capsules

Mankind Pharma Targets Early Semaglutide Launch

Zydus Gets USFDA Nod For Cevimeline HCL Capsules 30Mg

Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug

FDA Approves DifGen's Generic Mesalamine ER (250mg/500mg)

Bicycle Pumps Brakes on Lead Program, Deflates Headcount by 30%

Pfizer's Ibrance Heir Reduces Risk of Death in Ph 2 Breast Cancer

SC Grills SEBI on Sandesara Probe Despite 5,100 Cr Settlement

Astellas Ends $1.6B Biobucks TCE Pact With Cytomx After 6 Years

Lilly's Ebglyss Scores Eczema Trial Win in Children

Roche Launches NVIDIA AI Factory for Therapeutics, Diagnostics

Piramal Pharma Solutions' UK Facility Achieves 1,500th ADC Batch

Structure Climbs on 'Competitive' Profile for Weight Loss Pill

Sun Pharma Announces US FDA Acceptance of sBLA for ILUMYA

Amlogenyx Reveals AM805, Preclinical Success In Alzheimer Disease

Propane Shortage Hits Indian Pharma, Endangering Vitamin Output

Rs 600 Cr Pharma Plant Makes Kathua India's Antibiotic Hub

Pharma Demands Premium High-Purity Naphthalene

Drug Ingredient Prices Surge 30%, Potentially Raising Drug Costs

Nonprofit Modernizes Manufacturing By Removing Capital Barrier

API Innovation Center Warns of Fragile U.S. Drug Supply Chain

EDQM Issued CEP Certificate for "metformin HCl Process-II"

Esteve CDMO Launches $15.5M Chicago API Facility Expansion

Blue Jet Healthcare Initiates Rs. 2.3B Pharma Plant Construction

Viral High-Protein Portions Signal Shift In GLP-1 Supply Chain

Health Ministry Amends D&C Rules To Mandate PACs Submission

KSRPO alerts state FDA about spurious drugs sold by fake doctor

DTAB Recommends Exemptions From Revised Schedule M Norms

TNHDA Urges Major Drug Regulatory Reforms After Coldrif Cough

APL Healthcare's Unit-IV Classified As VAI By The USFDA

India's Drug Quality Surveillance Surpasses 500K Samples Tested

CDSCO Advises Against Promoting Prescription Obesity Drugs

Lilly Finds Impurity in Compounded Version of Weight-loss Drug

Novo Nordisk receives FDA warning linked to US inspection in 2025

FDA Moves to Address Manufacturing-Related Approval Rejections

Cannabis Not As Effective For Mental Health Disorders

Prodeon Medical Gets FDA Clearance For Urocross Expander System

Heartflow Strengthens Heart Disease Care Continuum